[1]
“Outcome of Standard Induction Therapy with Daunorubicin and Ara-C (3+7) in Acute Myeloid Leukemia”, J Dhaka Med Coll, vol. 24, no. 2, pp. 141–145, Sep. 2016, doi: 10.3329/jdmc.v24i2.29626.